1 month agoDr. Martin Brenner, DVM, Ph.D. - CEO/CSO, iBio - Next Generation Cardiometabolic & Obesity MedicinesProgressPotentialAndPossibilities
6 months agoAmgen Stock Dips: New Safety Warnings for Promising Obesity Drug—What Investors Need to KnowKemalAhmedTV
1 year agoIf Psych Drugs Reduce Recovery Rates from 80% to 5%, Why Are We Using Them?Health Biz and Politics
8 months agoMedicamentos de Eli Lilly para bajar de peso reducen el riesgo de diabetes tipo 2, según estudioPRENSA
2 months agoEli Lilly Throws $27 Billion At America Because Tariffs Twisted Their Arm And They Liked ItNewsVids
5 months agoLilly invests $3 billion to expand Wisconsin plant as obesity drug demand soarsB.C. Begley